HIV-1 viral subtype differences in the rate of CD4+ T-Cell decline among HIV seroincident antiretroviral naive persons in rakai district, Uganda

Journal of Acquired Immune Deficiency Syndromes

Volumn 54, Issue 2, 2010, Pages 180-184

  Kiwanuka, Noah ^a,b   Robb, Merlin ^c   Laeyendecker, Oliver ^c,d   Kigozi, Godfrey ^b   Wabwire Mangen, Fred ^a   Makumbi, Fredrick E ^a,b   Nalugoda, Fred ^b   Kagaayi, Joseph ^b   Eller, Michael ^e   Eller, Leigh Anne ^e   Serwadda, David ^f   Sewankambo, Nelson K ^a   Reynolds, Steven J ^c   Quinn, Thomas C ^c,d   Gray, Ronald H ^g   Wawer, Maria J ^a   Whalen, Christopher C ^a,h  

^a MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES   (Uganda)

^b UGANDA VIRUS RESEARCH INSTITUTE   (Uganda)

^c HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^g JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^h UNIVERSITY OF GEORGIA   (United States)

Author keywords

Cell decline; HIV disease progression; HIV 1 subtypes; Rate of CD41

Indexed keywords

ANTIRETROVIRUS AGENT; COTRIMOXAZOLE;

ADOLESCENT; ADULT; AGE; ARTICLE; CD4+ T LYMPHOCYTE; CELL LOSS; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENDER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFECTION PREVENTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; UGANDA; VIRUS LOAD; VIRUS RECOMBINANT; VIRUS STRAIN;

ADOLESCENT; ADULT; AGE FACTORS; CD4 LYMPHOCYTE COUNT; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; SEX FACTORS; UGANDA; VIRAL LOAD; YOUNG ADULT;

EID: 77953062237     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181c98fc0     Document Type: Article

References (28)

1. +lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med. 1997;126:946-954.
2. Kaleebu P, French N, Mahe C, et al. Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in Uganda. J Infect Dis. 2002; 185:1244-1250.
3. Baeten JM, Chohan B, Lavreys L, et al. HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads. J Infect Dis. 2007;195:1177-1180.
4. Kiwanuka N, Laeyendecker O, Robb M, et al. Effect of HIV-1 subtypes on disease progression in a cohort of incident cases infected with pure subtypes, recombinants, and multiple subtypes, Rakai, Uganda. J Infect Dis. 2008;197:707-713.
5. Vasan A, Renjifo B, Hertzmark E, et al. Different rates of disease progression of HIV type 1 infection in Tanzania based on infecting subtype. Clin Infect Dis. 2006;42:843-852.
6. Anastos K, Gange SJ, Lau B, et al. Association of race and gender with HIV-1 RNA levels and immunologic progression. J Acquir Immune Defic Syndr. 2000;24:218-226.
7. CASCADE Collaboration. Differences in CD4 cell counts at serocon-version and decline among 5739 HIV-1-infected individuals with well-estimated dates of seroconversion. J Acquir Immune Defic Syndr. 2003; 34:76-83.
8. Holmes CB, Wood R, Badri M, et al. CD4 decline and incidence of opportunistic infections in Cape Town, South Africa: implications for prophylaxis and treatment. J Acquir Immune Defic Syndr. 2006;42: 464-469.
9. Urassa W, Bakari M, Sandstrom E, et al. Rate of decline of absolute number and percentage of CD4 T lymphocytes among HIV-1-infected adults in Dar es Salaam, Tanzania. AIDS. 2004;18:433-438.
10. Katubulushi M, Zulu I, Yavwa F, et al. Slow decline in CD4 cell count in a cohort of HIV-infected adults living in Lusaka, Zambia. AIDS. 2005;19: 102-103.
11. Arroyo MA, Hoelscher M, Sanders-Buell E, et al. HIV type 1 subtypes among blood donors in the Mbeya region of southwest Tanzania. AIDS Res Hum Retroviruses. 2004;20:895-901.
12. Hoelscher M, Dowling WE, Sanders-Buell E, et al. Detection of HIV-1 subtypes, recombinants, and dual infections in east Africa by a multi-region hybridization assay. AIDS. 2002;16:2055-2064.
13. Fidler S, Fox J, Touloumi G, et al. Slower CD4 cell decline following cessation of a 3 month course of HAART in primary HIV infection: findings from an observational cohort. AIDS. 2007;21: 1283-91.
14. + T-cell decline and clinical outcomes in antiretroviral naive patients receiving universal healthcare. AIDS. 2009;23:731-737.
15. Laird NM, Ware JH. Random effects models for longitudinal data. Biometrics. 1982;38:963-974.
16. Singer JD, Willet JB. Applied Longitudinal Data Analysis: Modeling Change and Event Occurrence. 1st ed. New York: Oxford University Press; 2003.
17. Kofoed K, Gerstoft J, Mathiesen LR, et al. Syphilis and human immunodeficiency virus (HIV)-1 coinfection: influence on CD4 T-cell count, HIV-1 viral load, and treatment response. Sex Transm Dis. 2006; 33:143-148.
18. Buchacz K, Patel P, Taylor M, et al. Syphilis increases HIV viral load and decreases CD4 cell counts in HIV-infected patients with new syphilis infections. AIDS. 2004;18:2075-2079.
19. Kiwanuka N, Gray RH, Serwadda D, et al. The incidence of HIV-1 associated with injections and transfusions in a prospective cohort, Rakai, Uganda. AIDS. 2004;18:342-344.
20. Tscherning C, Alaeus A, Fredriksson R, et al. Differences in chemokine coreceptor usage between genetic subtypes of HIV-1. Virology. 1998;241: 181-188.
21. De Wolf F, Hogervorst E, Goudsmit J, et al. Syncytium-inducing and nonsyncytium-inducing capacity of human immunodeficiency virus type 1 subtypes other than B: phenotypic and genotypic characteristics. WHO Network for HIV Isolation and Characterization. AIDS Res Hum Retroviruses. 1994;10:1387-1400.
22. Kaleebu P, Nankya IL, Yirrell DL, et al. Relation between chemokine receptor use, disease stage, and hiv-1 subtypes A and D: results from a rural Ugandan cohort. J Acquir Immune Defic Syndr. 2007;45:28-33.
23. Shepherd JC, Laeyendecker O, Serwadda D. Reduced transmission of HIV-1 subtype D compared with subtype A in Rakai, Uganda. Infectious Diseases Society of America 2004 Annual Meeting Abstract 98.
24. Lugada ES, Mermin J, Kaharuza F, et al. Population-based hematologic and immunologic reference values for a healthy Ugandan population. Clin Diagn Lab Immunol. 2004;11:29-34.
25. Kibaya RS, Bautista CT, Sawe FK, et al. Reference ranges for the clinical laboratory derived from a rural population in Kericho, Kenya. PLoS ONE. 2008;3:e3327. doi:10.1371/journal.pone.0003327.
26. Saathoff E, Schneider P, Kleinfeldt V, et al. Laboratory reference values for healthy adults from southern Tanzania. Tropical Med Int Health. 2008; 13:1-14.
27. Fellay J, Shianna KV, Ge D, et al. A whole-genome association study of major determinants for host control of HIV-1. Science. 2007;317: 944-947.
28. WHO clinical staging for HIV/AIDS and HIV/AIDS case definitions for surveillance: African Region. http://www.who.int/hiv/pub/guidelines/ clinicalstaging.pdf. 2005.